DIFMUNIZE Trademark

Trademark Overview


On Tuesday, June 28, 2022, a trademark application was filed for DIFMUNIZE with the United States Patent and Trademark Office. The USPTO has given the DIFMUNIZE trademark a serial number of 97479415. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Wednesday, November 6, 2024. This trademark is owned by Pfizer Inc.. The DIFMUNIZE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use
difmunize

General Information


Serial Number97479415
Word MarkDIFMUNIZE
Filing DateTuesday, June 28, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateWednesday, November 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 18, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 18, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10001-2192

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Friday, July 1, 2022NEW APPLICATION ENTERED
Monday, July 18, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 14, 2023ASSIGNED TO EXAMINER
Thursday, March 16, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 29, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 18, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, April 26, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 26, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 26, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 26, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 26, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 6, 2023ASSIGNED TO EXAMINER
Tuesday, June 13, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, November 13, 2023SOU TEAS EXTENSION RECEIVED
Monday, November 13, 2023SOU EXTENSION 1 FILED
Monday, November 13, 2023SOU EXTENSION 1 GRANTED
Wednesday, November 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 14, 2024SOU EXTENSION 2 FILED
Tuesday, May 14, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, May 14, 2024SOU EXTENSION 2 GRANTED
Wednesday, May 15, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 6, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, November 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 6, 2024SOU EXTENSION 3 GRANTED
Wednesday, November 6, 2024SOU EXTENSION 3 FILED